Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Stem Cell Biology

Background:

• Sternal defects pose significant reconstruction challenges.
• Autografts and allografts have limitations in current sternal repair.
• Mesenchymal stem cells offer potential for tissue engineering.

Purpose of the Study:

• To evaluate the efficacy of osseous grafts engineered from amniotic mesenchymal stem cells (aMSCs) for postnatal sternal repair.
• To assess the feasibility of using amniotic fluid as a cell source for engineered chest wall reconstruction.

Main Methods:

• Leporine aMSCs were isolated, identified, and genetically modified (GFP).
• Cells were seeded onto biodegradable nanofibrous scaffolds and cultured in osteogenic medium.
• Constructs were used to repair full-thickness sternal defects in rabbits and analyzed after 2 months.

Main Results:

• All animals demonstrated successful defect closure via chest roentgenograms and necropsy.
• Graft density significantly increased in vivo, with evidence of ongoing remodeling.
• Histology confirmed the presence of GFP-positive cells within the grafts with minimal inflammation.

Conclusions:

• Engineered osseous grafts from aMSCs represent a viable alternative for sternal repair.
• Amniotic fluid is a practical cell source for engineered chest wall reconstruction applications.